Combretastatin A4 Prodrug: OXGN began a dose-ranging U.S. Phase Ib trial of combretastatin in combination with carboplatin in up to 35 patients. OXGN said the h

OxiGene Inc. (OXGN; SSE:OXGN), Boston, Mass.
Product: Combretastatin A4 Prodrug

Read the full 103 word article

How to gain access

Continue reading with a
two-week free trial.